-$541.5M
Net Activity
Institutions Holding
191
Popularity Rank
#3011
Avg Weight
0.02%
Total Value
$56.8M
191 institutions currently hold GOSS, with 111 net buyers and 111 net sellers this quarter.
Institutional Moves (Q1 2026)
Neutral
Based on recent trading activity
Net Selling Institutions
111
Net Buying Institutions
111
Top 5 by Value
+$27.5M
Total Buy Value
$381.5M
Total Sell Value
111
Net Buyers
111
Net Sellers
No Form 144 planned sale filings in the last 90 days
1
Active 5%+ Holders
| Reporting Person | Type | Filing Date | % of Class |
|---|---|---|---|
| D. E. Shaw Valence Portfolios, L.L.C. | 13D/A | 2026-07-01 | 8.3% |
2
Filings (14d)
At a special meeting on July 14, 2026, Gossamer Bio stockholders approved a restated incentive award plan. The plan, which the board had previously conditioned on stockholder approval and the closing of a $200 million convertible note exchange offer, increases the number of shares of common stock available for future grants. The exchange offer closed on June 4.
View Full Filing (SEC EDGAR)No AI summary for this filing type
View Full Filing (SEC EDGAR)The most-added stocks by 13F institutions this quarter
Institutions Holding
6,150
Total reported value
$2.1T
3245 13F institutions increased their position this quarter
Institutions Holding
5,957
Total reported value
$1.5T
3028 13F institutions increased their position this quarter
Institutions Holding
5,764
Total reported value
$3.0T
2743 13F institutions increased their position this quarter